Amphastar Pharmaceuticals(AMPH) - 2024 Q1 - Quarterly Results

EXHIBIT 99.1 Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024 Reports Net Revenues of $171.8 Million for the Three Months Ended March 31, 2024 RANCHO CUCAMONGA, CA – May 8, 2024 – Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) ("Amphastar" or the "Company") today reported results for the three months ended March 31, 2024. First Quarter Highlights ● Net revenues of$171.8 million for the first quarter ● GAAP net income of $43.2 million, or$0.81 per share, for the ...